Myocardial Dysfunction
25
1
4
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
2 terminated out of 25 trials
83.3%
-3.2% vs benchmark
4%
1 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (25)
Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study
Prognosis Impact of NSVTs After an AMI (TeVeO Study).
POWER Myocardial Fatigue Study: a Biomechanical Assessment of Contractility of Human Myocardium
Cardiac FDG PET Viability Registry
The Relationship Between Inflammatory ARTritis and CArdiac DIseAse
Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function
Effects of High-intensity Interval Training on Myocardial Strain in Metabolic Syndrome Patients
Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism
Myocardial Function and Vitamin D Supplementation in Diabetes.
Monitoring Drug-induced Myocarditis (CardiTOX)
Myocardial Deformation Before and After Birth
Effects of L-arginine on Myocardial Energetic Efficiency and Global Longitudinal Strain
The Effect of Inflammation in Heart Failure
Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility
Strain Analysis for Assessment of Myocardic Dysfunction During Orthotopic Liver Transplantation
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH
Fetal Myocardial Performance Index in Diabetic Pregnancies
Coronary Microvascular Dysfunction in Chronic Kidney Disease
STOP Heart Disease in Breast Cancer Survivors Trial